mAbDx scientific staff are experienced in development of monoclonal antibodies and immunoassays for basic and clinical diagnostic research. Active collaborations are encouraged on novel approaches to develop tests for the diagnosis and study of diseases of significant clinical urgency and for which such reagents are lacking.  We have a strong track record of obtaining SBIR/STTR grant funding and, more importantly, of successfully putting such funding to use developing and commercializing high-value immunochemical products.

Inquiries and opportunities regarding potential research collaborations should be directed to:

Michael F. Marusich, PhD., Chief Scientific Officer
mAbDx, Inc.

Consulting services are also available for antibody and immunoassay development, including the design and application of novel screening protocols and assay platforms.

For further information regarding consulting services, contact: